Literature DB >> 21928280

Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding.

Sonia Agüera-González1, Catharina C Gross, Lola Fernández-Messina, Omodele Ashiru, Gloria Esteso, Howard C Hang, Hugh T Reyburn, Eric O Long, Mar Valés-Gómez.   

Abstract

MICA and MICB (MHC-class-I-related chain A/B) are transmembrane proteins expressed in pathological conditions that are ligands for NKG2D, an activating receptor found on cytotoxic lymphocytes. The recognition on target cells of NKG2D ligands leads to the activation of lysis and cytokine secretion by NK cells and T cells. Besides being expressed at the cell surface, MICA/B can be released as soluble proteins. Soluble NKG2D ligands downmodulate expression of the NKG2D receptor on lymphocytes, leading to a diminished cytotoxic response. Prior studies suggested that recruitment of MICA/B molecules to cholesterol-enriched microdomains was an important factor regulating the proteolytic release of these molecules. We now show that recruitment of MICA to these microdomains depends on palmitoylation of two cysteine residues that allow MICA molecules to reside in the membrane in the same domains as caveolin-1. Compared with WT molecules, nonpalmitoylated mutant MICA molecules were shed to the supernatant with low efficiency; however, both WT and mutant MICA were able to trigger NK cell cytotoxicity. These data suggest that the presence of NKG2D ligands at the plasma membrane is sufficient to activate cytotoxicity and reflect the need of different ligands to exploit different cellular pathways to reach the cell surface upon different stress situations.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928280      PMCID: PMC3709245          DOI: 10.1002/eji.201141645

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  42 in total

1.  Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells.

Authors:  Howard C Hang; Ernst-Jan Geutjes; Gijsbert Grotenbreg; Annette M Pollington; Marie Jose Bijlmakers; Hidde L Ploegh
Journal:  J Am Chem Soc       Date:  2007-02-17       Impact factor: 15.419

Review 2.  Immunobiology of human NKG2D and its ligands.

Authors:  S González; V Groh; T Spies
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 3.  Discovery of protein-palmitoylating enzymes.

Authors:  Ryouhei Tsutsumi; Yuko Fukata; Masaki Fukata
Journal:  Pflugers Arch       Date:  2008-01-30       Impact factor: 3.657

Review 4.  Palmitoylation of membrane proteins (Review).

Authors:  Julie Charollais; F Gisou Van Der Goot
Journal:  Mol Membr Biol       Date:  2008-12-10       Impact factor: 2.857

5.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

Authors:  Cyril Fauriat; Eric O Long; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Blood       Date:  2009-12-01       Impact factor: 22.113

6.  Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids.

Authors:  Y Webb; L Hermida-Matsumoto; M D Resh
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

7.  The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases.

Authors:  Gang Liu; Catherine L Atteridge; Xuanjun Wang; Ashley D Lundgren; Jennifer D Wu
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

8.  Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains.

Authors:  B Annabi; M Lachambre; N Bousquet-Gagnon; M Pagé; D Gingras; R Béliveau
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

9.  Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells.

Authors:  Beatriz G Gálvez; Salomón Matías-Román; María Yáñez-Mó; Miguel Vicente-Manzanares; Francisco Sánchez-Madrid; Alicia G Arroyo
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

10.  Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.

Authors:  Konstantina Eleme; Sabrina B Taner; Björn Onfelt; Lucy M Collinson; Fiona E McCann; N Jan Chalupny; David Cosman; Colin Hopkins; Anthony I Magee; Daniel M Davis
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

View more
  18 in total

1.  Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.

Authors:  A Baragaño Raneros; V Martín-Palanco; A F Fernandez; R M Rodriguez; M F Fraga; C Lopez-Larrea; B Suarez-Alvarez
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

2.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.

Authors:  Hong Jiang; Xiaoyu Zhang; Xiao Chen; Pornpun Aramsangtienchai; Zhen Tong; Hening Lin
Journal:  Chem Rev       Date:  2018-01-02       Impact factor: 60.622

Review 3.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  MICA variant promotes allosensitization after kidney transplantation.

Authors:  Pierre Tonnerre; Nathalie Gérard; Mathias Chatelais; Caroline Poli; Stéphanie Allard; Sylvie Cury; Céline Bressollette; Anne Cesbron-Gautier; Béatrice Charreau
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

Review 5.  Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.

Authors:  Ahmed El-Gazzar; Veronika Groh; Thomas Spies
Journal:  J Immunol       Date:  2013-08-15       Impact factor: 5.422

6.  Human NKG2D-ligands: cell biology strategies to ensure immune recognition.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2012-09-25       Impact factor: 7.561

7.  A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.

Authors:  Dan Chen; Joanna Hammer; David Lindquist; Annika Idahl; Ulf Gyllensten
Journal:  Cancer Med       Date:  2014-01-07       Impact factor: 4.452

8.  Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer.

Authors:  Jiong Chen; Hong Xu; Xing-Xing Zhu
Journal:  Ther Clin Risk Manag       Date:  2015-12-22       Impact factor: 2.423

9.  Identification of SH3 domain proteins interacting with the cytoplasmic tail of the a disintegrin and metalloprotease 10 (ADAM10).

Authors:  Henriette Ebsen; Marcus Lettau; Dieter Kabelitz; Ottmar Janssen
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

Review 10.  Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention.

Authors:  Aroa Baragaño Raneros; Beatriz Suarez-Álvarez; Carlos López-Larrea
Journal:  Oncoimmunology       Date:  2014-04-25       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.